Source:http://linkedlifedata.com/resource/pubmed/id/15331161
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-8-27
|
pubmed:abstractText |
Glycosylation influences the biological activity of proteins and affects their folding and stability. Because aberrant glycosylation is associated with Alzheimer's disease (AD), we applied proteome analysis together with Pro-Q Emerald 300 glycoprotein staining to investigate changes in glycosylated cytosolic proteins in AD and control brain. Frontal cortex proteins from 10 AD patients and 7 non-demented controls were subjected to separation by two-dimensional gel electrophoresis and subsequently stained with carbohydrate-specific Pro-Q Emerald 300 dye. Changes in glycosylation of separated proteins were quantified, and proteins of interest identified by mass spectrometry. Approximately 30% of all detectable proteins in the human frontal cortex appeared glycosylated, including heat shock cognate 71 stress protein and beta isoform of creatine kinase. The glycosylation of collapsin response mediator protein 2 (CRMP-2) and an unknown protein was reduced in AD, while the glycosylation of glial fibrillary acidic protein was increased. CRMP-2 regulates the assembly and polymerization of microtubules and is associated with neurofibrillary tangles in AD. Aberrant glycosylations in AD may help understand the mechanisms of neurodegenerative diseases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Coloring Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Glial Fibrillary Acidic Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/collapsin response mediator...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
367
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
235-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15331161-Aged,
pubmed-meshheading:15331161-Aged, 80 and over,
pubmed-meshheading:15331161-Alzheimer Disease,
pubmed-meshheading:15331161-Brain Chemistry,
pubmed-meshheading:15331161-Coloring Agents,
pubmed-meshheading:15331161-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:15331161-Female,
pubmed-meshheading:15331161-Frontal Lobe,
pubmed-meshheading:15331161-Glial Fibrillary Acidic Protein,
pubmed-meshheading:15331161-Glycoproteins,
pubmed-meshheading:15331161-Glycosylation,
pubmed-meshheading:15331161-Humans,
pubmed-meshheading:15331161-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:15331161-Male,
pubmed-meshheading:15331161-Nerve Tissue Proteins,
pubmed-meshheading:15331161-Proteomics
|
pubmed:year |
2004
|
pubmed:articleTitle |
Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
|
pubmed:affiliation |
Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Neulaniementie 2, P.O. Box 1627, FIN-70211 Kuopio, Finland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|